Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
[Journal of Endocrinology & Metabolism] Obesity drug codenamed AOD9604 highly successful in trials, News-Medical.net, 16-Dec-2004
The oral form is often chosen for gut-related goals, on the rationale that it acts on the GI lining as it passes through the digestive tract though this rationale comes from animal research, and BPC-157 has not been shown in human trials to treat any specific gastrointestinal condition
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH)
Stimulates the healing of the bones and ligaments by promoting improved cell survival and cell migration
Use our BPC-157 Dosage Calculator for personalized guidance
Unlike the full hormone that affects growth, this fragment appears to specifically target fat cells in experimental settings
US$ 29.71
US$ 27.44
US$ 27.19
US$ 28.33
US$ 28.30
US$ 26.90
